Market Tracker

01/16 7:28am ET

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.875
Delayed Data
As of Jan 13
 +0.0505 / +6.12%
Today’s Change
0.65
Today|||52-Week Range
2.64
+26.85%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.82
Today’s open0.85
Day’s range0.83 - 0.91
Volume376,346
Average volume (3 months)92,185
Market cap$21.1M
Dividend yield--
Data as of 4:02pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-32.49%
P/E ratioNM
Price/Sales142.93
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
MBVXMabVax Therapeutics ...-0.01-0.29%
TNXPTonix Pharmaceutical...+0.02+2.91%
SBOTStellar Biotechnolog...-0.03-1.32%
HTBXHeat Biologics Inc-0.02-1.96%
Data as of 4:00pm ET, 01/13/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$133.0K
Annual profit (last year)-$15.2M
Net profit margin-11,451.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Secretary
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts